|
Volumn 50, Issue 4, 2010, Pages 401-414
|
Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 (1 BIPHENYL 4 YLMETHYL 3 ETHOXYCARBONYL 1 BUTYLCARBAMOYL)PROPIONATE 3' METHYL 2' (PENTANOYL(2' (TETRAZOL 5 YLATE)BIPHENYL 4' YLMETHYL)AMINO)BUTYRATE;
3-(1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-3'-METHYL-2'-(PENTANOYL(2'-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE;
AMINOBUTYRIC ACID DERIVATIVE;
ANGIOTENSIN RECEPTOR;
MEMBRANE METALLOENDOPEPTIDASE;
TETRAZOLE DERIVATIVE;
ADOLESCENT;
ADULT;
ANIMAL;
ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOG;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
DRUG SCREENING;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
RAT;
SPRAGUE DAWLEY RAT;
TRANSGENIC RAT;
ADOLESCENT;
ADULT;
AMINOBUTYRIC ACIDS;
ANIMALS;
COHORT STUDIES;
CROSS-OVER STUDIES;
DOGS;
DOUBLE-BLIND METHOD;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
MALE;
MIDDLE AGED;
NEPRILYSIN;
RATS;
RATS, SPRAGUE-DAWLEY;
RATS, TRANSGENIC;
RECEPTORS, ANGIOTENSIN;
TETRAZOLES;
YOUNG ADULT;
MLCS;
MLOWN;
|
EID: 77956817833
PISSN: None
EISSN: 15524604
Source Type: Journal
DOI: 10.1177/0091270009343932 Document Type: Article |
Times cited : (446)
|
References (0)
|